Sessions are scheduled in Singapore Time (SGT)

Displaying One Session

View
Hall 405 Educational session

Risk-adapted strategy in HR+/HER2 negative early breast cancer

Date
Fri, 02.12.2022
Time
14:30 - 16:00
Location
Hall 405
Chairs
  • Suzette Delaloge (Villejuif, France)
  • Elaine Lim (Singapore, Singapore)
Risk-adapted strategy in HR+/HER2 negative early breast cancer Educational session

Defining the risk from clinical assessment to genomic classifiers: Does ethnicity matter?

Lecture Time
14:30 - 14:55
Speakers
  • Yoon Sim Yap (Singapore, Singapore)
Session Name
Risk-adapted strategy in HR+/HER2 negative early breast cancer
Location
Hall 405, Singapore, Singapore, Singapore
Date
Fri, 02.12.2022
Time
14:30 - 16:00
Risk-adapted strategy in HR+/HER2 negative early breast cancer Educational session

When can chemotherapy be omitted and how does menopausal status matter?

Lecture Time
14:55 - 15:20
Speakers
  • Christos Sotiriou (Brussels, Belgium)
Session Name
Risk-adapted strategy in HR+/HER2 negative early breast cancer
Location
Hall 405, Singapore, Singapore, Singapore
Date
Fri, 02.12.2022
Time
14:30 - 16:00
Risk-adapted strategy in HR+/HER2 negative early breast cancer Educational session

Escalating strategies over standard of care as adjuvant treatment therapy in HR+HER2- EBC: Where do we stand?

Lecture Time
15:20 - 15:45
Speakers
  • Valentina Guarneri (Padova, Italy)
Session Name
Risk-adapted strategy in HR+/HER2 negative early breast cancer
Location
Hall 405, Singapore, Singapore, Singapore
Date
Fri, 02.12.2022
Time
14:30 - 16:00
Risk-adapted strategy in HR+/HER2 negative early breast cancer Educational session

Q&A and discussion

Lecture Time
15:45 - 16:00
Speakers
  • Suzette Delaloge (Villejuif, France)
Session Name
Risk-adapted strategy in HR+/HER2 negative early breast cancer
Location
Hall 405, Singapore, Singapore, Singapore
Date
Fri, 02.12.2022
Time
14:30 - 16:00